CAR- T as well as mobile gene treatments are actually too pricey

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production as well as modern technology transfer can easily provide cellular genetics treatments at a cost effective cost to people all over the world.